Candriam Equities L Biotechnology Class R2 Fonds
228,65
USD
-7,93
USD
-3,35
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Gilead Sciences Inc | US3755581036 | 7,48% |
| Amgen Inc | US0311621009 | 6,31% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 5,92% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 5,83% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,99% |
| BioNTech SE ADR | US09075V1026 | 3,26% |
| Insmed Inc | US4576693075 | 2,73% |
| Ascendis Pharma AS ADR | US04351P1012 | 2,52% |
| BeiGene Ltd ADR | US07725L1026 | 2,48% |
| Biomarin Pharmaceutical Inc | US09061G1013 | 2,34% |
| Sonstige | 57,14% |